FDA warns patients to stop using six lots of compounded injections
The FDA posted a nationwide recall of six Centric Compounding injection lots after the company reported elevated endotoxin levels and nine reaction reports.
Patient Safety
-
-
FDA tells hospitals to inspect certain infant breathing circuits
The FDA says hospitals should inspect Draeger VentStar Resus Neo circuits for cracked or detached hoses before use and discard damaged units.
-
FDA Classifies Luna G3 Recall After Firmware Could Stop Therapy
FDA classified a nationwide Luna G3 APAP recall after firmware may trigger shutdowns under specific conditions. Patients should check their device.
-
State report details pharmacy failures in Nashville hospital medication mix-up
A Tennessee Health Facilities Commission report says four Ascension Saint Thomas Midtown patients received potassium phosphate instead of mepivacaine after multiple pharmacy and verification safeguards failed.
-
Northern Louisiana Medical Center still faces an August 30 Medicare deadline after follow-up inspection
Northern Louisiana Medical Center reduced its alleged deficiencies from 24 to 14 in a July follow-up, but regulators had not publicly confirmed full compliance 16 days before the hospital’s stated August 30 Medicare deadline.
-
Weill Cornell Medicine resolves DOJ criminal investigation with patient-safety agreement
The Justice Department says Weill Cornell Medicine resolved a criminal investigation through an agreement requiring the medical institution to maintain and enhance measures intended to prevent sexual abuse of patients.
-
FDA posts nationwide recall of cyclophosphamide injections after steel particles found
The FDA published a nationwide, user-level recall of three Sunny Pharmtech cyclophosphamide lots after steel particulate matter was identified in 1-gram and 2-gram vials.
-
CMS will use shorter surveys for some nursing homes starting Sept. 8
CMS will begin shorter routine surveys for some high-performing nursing homes on September 8, but complaints and safety concerns can still trigger traditional inspections.
-
FDA Classifies Abiomed Impella Kit Recall as Class I
The FDA classified a recall of select Abiomed introducer kits as Class I after thrombus reports. Hospitals should stop use, quarantine units and arrange returns.
-
Baxter Recalls One Cefazolin IV Bag Lot Over Cardboard Particles
FDA posted Baxter’s voluntary recall of one nationwide-distributed cefazolin IV-bag lot after cardboard particles were found in the solution.
-
Nationwide B. Braun IV recall flags two Lactated Ringer’s lots
B. Braun recalled two lots of Lactated Ringer’s Injection, 1L, after particulate matter was found in solution, prompting hospital safety checks.